These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32909893)

  • 61. The Dutch chronic lower limb-threatening ischemia registry (THRILLER): A study protocol for popliteal and infrapopliteal endovascular interventions.
    Nugteren MJ; Hazenberg CEVB; Akkersdijk GP; Bakker OJ; Dinkelman MK; Fioole B; van den Heuvel DAF; Heyligers JMM; Hinnen JW; Pierie M; Schouten O; Schreve MA; Verhoeven BAN; de Borst GJ; Ünlü Ç
    PLoS One; 2023; 18(7):e0288912. PubMed ID: 37471351
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A Propensity-Matched Analysis of Endovascular Intervention versus Open Nonautologous Bypass as Initial Therapy in Patients with Chronic Limb-Threatening Ischemia.
    Futchko J; Friedmann P; Phair J; Trestman EB; Denesopolis J; Shariff S; Scher LA; Lipsitz EC; Porreca F; Garg K
    Ann Vasc Surg; 2021 Aug; 75():194-204. PubMed ID: 33819581
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Geriatric Nutritional Risk Index predicts amputation after infrapopliteal angioplasty in critical limb ischemia patients.
    Ruangsetakit C; Navikaputra S; Pruekprasert K; Prapassaro T; Puangpunngam N; Hongku K; Hahtapornsawan S; Chinsakchai K; Wongwanit C; Sermsathanasawadi N
    Asian J Surg; 2023 Jan; 46(1):250-253. PubMed ID: 35365390
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparative 12-Month Outcomes of Drug-Coated Balloon Versus Non-Drug-Coated Balloon Revascularization Strategy in Chronic Limb-Threatening Ischemia: Results From the XLPAD Registry.
    Giannopoulos S; Jeon-Slaughter H; Kahlon RS; Tejani I; Baskar A; Banerjee S; Armstrong EJ
    Cardiovasc Revasc Med; 2020 Oct; 21(10):1276-1284. PubMed ID: 32249170
    [TBL] [Abstract][Full Text] [Related]  

  • 65. BAlloon versus Stenting in severe Ischaemia of the Leg-3 (BASIL-3): study protocol for a randomised controlled trial.
    Hunt BD; Popplewell MA; Davies H; Meecham L; Jarrett H; Bate G; Grant M; Patel S; Hewitt C; Andronis L; Deeks JJ; Bradbury A;
    Trials; 2017 May; 18(1):224. PubMed ID: 28526046
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A description of the severity and extent of disease using the Bollinger angiogram scoring method and the TransAtlantic Inter-Society Consensus II classification.
    Bradbury AW; Adam DJ; Bell J; Forbes JF; Fowkes FG; Gillespie I; Ruckley CV; Raab GM;
    J Vasc Surg; 2010 May; 51(5 Suppl):32S-42S. PubMed ID: 20435260
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Strategy of Revascularization for Critical Limb Ischemia Due to Infragenicular Lesions-Which Should Be Selected Firstly, Bypass Surgery or Endovascular Therapy?
    Ohmine T; Iwasa K; Yamaoka T
    Ann Vasc Dis; 2015; 8(4):275-81. PubMed ID: 26730251
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Angiosome-Targeted Infrapopliteal Angioplasty: Impact on Clinical Outcomes-An Observational Study.
    Popitiu MI; Alexandrescu VA; Clerici G; Ionac S; Gavrila-Ardelean G; Ion MG; Ionac ME
    J Clin Med; 2024 Feb; 13(3):. PubMed ID: 38337576
    [No Abstract]   [Full Text] [Related]  

  • 69. Patient selection and perioperative outcomes of bypass and endovascular intervention as first revascularization strategy for infrainguinal arterial disease.
    Bodewes TCF; Darling JD; Deery SE; O'Donnell TFX; Pothof AB; Shean KE; Moll FL; Schermerhorn ML
    J Vasc Surg; 2018 Jan; 67(1):206-216.e2. PubMed ID: 28844467
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of lower extremity bypass and peripheral vascular intervention for chronic limb-threatening ischemia in the Medicare-linked Vascular Quality Initiative.
    Cleman J; Romain G; Grubman S; Guzman RJ; Smolderen KG; Mena-Hurtado C
    J Vasc Surg; 2023 Sep; 78(3):745-753.e6. PubMed ID: 37207790
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Optimal medical management in patients undergoing peripheral vascular interventions for chronic limb-threatening ischemia is associated with improved outcomes.
    Chang M; O'Brien-Irr MS; Shaw JF; Montross BC; Dosluoglu HH; Harris LM; Dryjski ML; Khan SZ
    J Vasc Surg; 2023 Aug; 78(2):490-497. PubMed ID: 37150486
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The natural history of chronic limb-threatening ischemia after technical failure of endovascular intervention.
    Campbell DB; Sobol CG; Sarac TP; Stacy MR; Atway S; Go MR
    J Vasc Surg; 2023 Sep; 78(3):737-744. PubMed ID: 37141950
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Open revascularization approach is associated with healing and ambulation after transmetatarsal amputation in patients with chronic limb threatening ischemia.
    Gomez-Sanchez C; Werlin E; Sorrentino T; El Khoury R; Lancaster E; Parks C; Goodman B; Dini M; Iannuzzi J; Reyzelman A; Conte MS; Gasper W
    J Vasc Surg; 2023 Apr; 77(4):1147-1154.e3. PubMed ID: 36581012
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Infrapopliteal angioplasty for critical limb ischemia: relation of TransAtlantic InterSociety Consensus class to outcome in 176 limbs.
    Giles KA; Pomposelli FB; Spence TL; Hamdan AD; Blattman SB; Panossian H; Schermerhorn ML
    J Vasc Surg; 2008 Jul; 48(1):128-36. PubMed ID: 18502084
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Limb-based patency as a measure of effective revascularization for chronic limb-threatening ischemia.
    El Khoury R; Wu B; Kupiec-Weglinski SA; Liu IH; Edwards CT; Lancaster EM; Hiramoto JS; Vartanian SM; Schneider PA; Conte MS
    J Vasc Surg; 2022 Oct; 76(4):997-1005.e2. PubMed ID: 35697305
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Society for Vascular Surgery Objective Performance Goals for Critical Limb Ischemia are attainable in select patients with ischemic wounds managed with wound care alone.
    Crowner JR; Marston WA; Freeman NLB; Sperger J; Austin HD; Steffan M; Farber MA; Chung J; McGinigle KL
    Ann Vasc Surg; 2022 Jan; 78():28-35. PubMed ID: 34543715
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparison of clinical outcomes, including the wound healing rate, between inframalleolar bypass to the pedal artery and that to the pedal branch artery in the modern endovascular era.
    Kodama A; Kobayashi T; Guntani A; Yamada T; Koyama A; Mii S; Ishibashi H; Matsushita M; Komori K
    J Vasc Surg; 2022 Jun; 75(6):2019-2029.e2. PubMed ID: 35182663
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Outcomes of lower extremity arterial bypass using the Human Acellular Vessel in patients with chronic limb-threatening ischemia.
    Cifuentes S; Sen I; Shuja F; Mendes BC; Colglazier JJ; Schaller MS; Kalra M; Morrison JJ; DeMartino RR; Rasmussen TE
    J Vasc Surg; 2024 Feb; 79(2):348-357.e2. PubMed ID: 37890643
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In Situ Vein Bypass Is Superior to Endovascular Treatment of Femoropopliteal Lesions in Chronic Limb-Threatening Ischemia.
    Lawaetz M; Fisker L; Lönn L; Sillesen H; Eiberg J
    Ann Vasc Surg; 2020 Aug; 67():437-447. PubMed ID: 32234573
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Bypass surgery for chronic lower limb ischaemia.
    Antoniou GA; Georgiadis GS; Antoniou SA; Makar RR; Smout JD; Torella F
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002000. PubMed ID: 28368090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.